“I worry when people ask, ‘How many stock options am I going to get?’ We hire people who want to cure diseases.”
–Art Levinson, chairman and CEO of Genentech, said this during Genentech’s investor day in New York City this past March. Yesterday Levinson raised Genentech’s earnings forecast, and the stock is up substantially in a down market.